Process for concentration of antibodies and therapeutic products thereof

Details for Australian Patent Application No. 2005285243 (hide)

International Classifications

Event Publications

15 March 2007 PCT application entered the National Phase

PCT publication WO2006/031560 Priority application(s): WO2006/031560

26 July 2007 Change of Name(s) of Applicant(s), Section 104

Genentech, Inc.; Novartis, AG The name of the applicant has been changed to Genentech, Inc.; Novartis AG

8 March 2012 Application Accepted

Published as AU-B-2005285243

28 June 2012 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 06 Jun 2012 . Address for service in Australia - Griffith Hack GPO Box 1285 Melbourne VIC 3001 2006

25 October 2012 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 06 Jun 2012 2006

25 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.